
Beginning September 1, 2015, Boston Maternal Fetal Medicine will now be offering advanced genetic testing through Good Start Genetics.
Since the introduction of the first commercially-available Noninvasive Prenatal Testing (NIPT) in 2011, there has been controversy over how best to perform aneuploidy screening in our patients. The Combined First Trimester Screening test, which employs measurement of the nuchal translucency combined with determination of the Learn More
A National Institute of Health Consensus panel convened last month to consider whether to recommend adoption of the one step, 2 hour glucose screening test proposed by The International Association of Diabetes and Pregnancy Study Groups (IADPSG) or to join ACOG in backing continuation of Learn More